Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people. (2020)

First Author: Jaspers NEM
Attributed to:  Aetiology of type 2 diabetes and related metabolic disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/eurheartj/ehz239

PubMed Identifier: 31102402

Publication URI: http://europepmc.org/abstract/MED/31102402

Type: Journal Article/Review

Volume: 41

Parent Publication: European heart journal

Issue: 11

ISSN: 0195-668X